Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?

被引：0
作者：
Avraham Ishay
Elena Chertok Shacham
机构：
[1] HaEmek Medical Center,Endocrinology Unit
[2] Faculty of Medicine,undefined
[3] Technion – Israel Institute of Technology,undefined
来源：
BMC Endocrine Disorders | / 23卷
关键词：
COVID-19 vaccine; Diabetes Insipidus; Hypophysitis; SARS-CoV-2; Case report;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 179 条
  • [1] Polack FP(2020)Safety and efficacy of the BNT162b2mRNA Covid-19 vaccine NEJM 383 2603-2615
  • [2] Thomas SJ(2021)SARS-CoV-2 Vaccines JAMA 325 1318-1320
  • [3] Kitchin N(2021)Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination JAMA Netw Open 4 e2140364-209
  • [4] Creech CB(2022)A Case of Hypophysitis Associated With SARS-CoV-2 Vaccination AACE Clin Case Rep 8 204-R239
  • [5] Walker SC(2021)Early and late endocrine complications of COVID-19 Endocr Connect 10 R229-2856
  • [6] Samuels SJ(2022)Impact of COVID-19 on the Endocrine System: A Mini-review Endocrinol 163 bqab203-231
  • [7] Beatty AL(2021)Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection J Endocrinol Invest 44 2855-176
  • [8] Peyser ND(2022)Central diabetes insipidus secondary to COVID-19 infection: a case report BMC Endocr Disord 22 134-2715
  • [9] Butcher XE(2022)COVID-19 and hypopituitarism Rev Endocr Metab Disord 23 215-2253
  • [10] Ankireddypalli AR(2022)Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine Therapie S0040–5957 00167-159
12345678910